Development and evaluation of carvedilol transdermal patches
By: Yuveraj Tanwar, Chetan Chauhan and Anshu Sharma
Open Access
|May 2007References
- R. R. Ruffolo, Jr. and G. Z. Feuerstein, Pharmacology of carvedilol: rational for use in hypertension, coronary artery disease, and congestive heart failure,(1997) 247-256.
- K. E. Thummel and D. D. Shen,, in(Eds. J. G. Hardman, L. E. Limbirel and A. G. Gilman), 10ed., Mc. Graw Hill, New York 2001, p. 1936.
- L. Landsberg and J. B. Young,, in(Eds. E. Braunwald, A. S. Fanci, D. L. Kasper, S. L. Hauser, D. L. Longo and J. L. Janeson), 15ed., Mc. Graw Hill, New York 2001, p. 447.
- U. V. Singh, S. Pandey and N. Udupa, Preparation and evaluation of flurbiprofen and diclofenac sodium transdermal films,(1993) 145-147.
- P. Arora and B. Mukherjee, Design, development, physicochemical, andandevaluation of transdermal patches containing diclofenac diethylammonium salt,(2002) 2076-2089.
- C. Amnuaikit, I. Ikeuchi, K. Ogawara, K. Higaki and T. Kimura, Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use,(2005) 167-178.
- P. R. P. Verma and S. S. Iyer, Transdermal delivery of propranolol using mixed grades of Eudragit: design andandevaluation,(2000) 471-476.
- V. K. Devi, S. Saisivam, G. R. Maria and P. U. Deepti, Design and evaluation of matrix diffusion controlled transdermal patches of verapamil hydrochloride,(2003) 495-503.
- R. Krishna and J. K. Pandit, Transdermal delivery of propranolol,(1994) 2459-2465.
- P. R. Keshary and Y. W. Chien, Mechanisms of transdermal nitroglycerin administration (I): development of finite-dosing skin permeation system,(1984) 883-913.
- G. K. Jain, A. K. Sharma and S. S. Agarwal, Transdermal controlled administration of verapamil-enhancement of skin permeability,(1996) 169-177.
- J. H. Draize, G. Woodard and H. O. Calvery, Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes,(1944) 377-390.
- C.-W. Cho and S.-C. Shin, Enhanced transdermal delivery of atenolol from the ethylene-vinyl acetate matrix,(2004) 67-71.
- R. W. Korsmeyer, R. Gurny, E. M. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers,(1983) 25-35.
- P. L. Ritger and N. A. Peppas, Simple equation for solute release. Part 1. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or disks,(1987) 37-42.
- V. Rao and S. Shyale, Preparation and evaluation of ocular inserts containing norfloxacin,(2004) 239-246.
- S. K. Sahoo, A. A. Mallick, B. B. Barik and P. Ch. Senapati, Formulation andevaluation of eudragit microspheres of stavudine,(2005) 369-375.
Language: English, Croatian
Page range: 151 - 159
Published on: May 16, 2007
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:
© 2007 Yuveraj Tanwar, Chetan Chauhan, Anshu Sharma, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.